October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

Emerson Forms Life Sciences Executive Board to Advance One-Click Technology Transfer Initiative

Get our GAP Insights Newsletter

Join Upcoming Events

October 18-20, 2023 / Tucson, AZ
The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

AUSTIN, TexasOct. 4, 2023 /PRNewswire/ — Global technology and software leader Emerson (NYSE: EMR) announced a new executive board of key life sciences leaders to help define, review and demonstrate prototypes for Emerson technologies that will safely speed life-saving drugs to market.

Collaborating through Emerson’s One-Click Technology Transfer™ Board, Emerson customers FUJIFILM Diosynth BiotechnologiesMerck and Pfizer will lead the development of strategies, solutions and guidelines to convert today’s life sciences manufacturing recipe transfer process into a digitalized production platform. Digitalizing recipe technology transfer will reduce the time, effort and risk of managing, sharing and translating information to help get new drug therapies to patients faster.

Emerson will also open a dedicated research center to accelerate the development of One-Click Technology Transfer software. Located in the Singapore life sciences manufacturing hub that is home to 8 of the 10 global pharmaceutical companies, Emerson’s new research center will design, develop and verify the software and digitalized production platform.

“What we learned through the pandemic was that with hyper-focused investment and coordination, new treatments can be brought to market safely and also at warp speed,” said Nathan Pettus, president of Emerson’s process systems and solutions business. “Bringing these key industry leaders together – and dedicating a new research center to advancing technology and standards – will help make the lessons learned more systemic, accelerating the development pipeline and safely supporting patients with life-saving and life-improving treatments.

“This industry is highly regulated to ensure that lifesaving and enriching medicines are of dependable and consistent quality,” continued Pettus.  “Emerson is proud to facilitate this process of innovation with so many leading companies to drive standards that will accelerate the adoption of new technologies and performance benefits they bring.”

Life sciences companies currently spend inordinate amounts of time and money to move information – recipes, process sequences, operating parameters, equipment characteristics, quality requirements and more – among disparate applications and databases including enterprise resource planning, process and knowledge management, maintenance management, quality management and automation systems.

Emerson’s One-Click Technology Transfer capabilities will help digitalize drug recipes and recipe management, from discovery and development to production at scale, providing valuable translations between drug recipe requirements and manufacturing processes while establishing best practices and creating a framework to unify disconnected systems into a holistic platform. The board will define reference data models and objects for one-click manufacturing, create the framework for a centralized recipe transport and translation platform that is scalable and extensible, and define and implement standards for version and quality control while simultaneously ensuring the overall system is easy and intuitive to use.


Full story: Emerson Forms Life Sciences Executive Board to Advance One-Click Technology Transfer Initiative

Get the Report

More GAP News